An observational trial investigating the efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in patients with atrial fibrillation.

Trial Profile

An observational trial investigating the efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in patients with atrial fibrillation.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Dec 2016

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Dec 2016 New trial record
    • 28 Nov 2016 Results published in the Clinical Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top